Sabby Management LLC

Sabby Mgmt Accuses Microcap Biotech of Destroying Value

Sabby Management, LLC August 29, 2012    To the Board of Directors of Cardium Therapeutics, Inc.   Sabby Management, LLC  and its associated funds (collectively, “Sabby”) have a collective beneficial ownership exceeding 8% of the current outstanding shares of Cardium Therapeutics, Inc. (“Cardium”).  The purpose of this letter is to express our profound dissatisfaction with…

Get insights in your inbox with the Oozing Alpha monthly newsletter.
Join Now!